Indian Equities Climb on IT Rally Ahead of RBI Policy, Earnings
Markets Daniel Marsh

Indian Equities Climb on IT Rally Ahead of RBI Policy, Earnings

Indian benchmarks advanced Tuesday, with the Nifty 50 closing above 23,100, driven by a rally in IT stocks ahead of quarterly earnings and the RBI's policy decision.

INFY FXI
Plug Power Surges on Major Quebec Hydrogen Deal Ahead of Investor Tour
Technology Sarah Chen

Plug Power Surges on Major Quebec Hydrogen Deal Ahead of Investor Tour

Plug Power shares rallied sharply following a significant electrolyzer contract award in Quebec. Company leadership is commencing a Canadian investor roadshow to discuss financial progress and growth strategy.

PLUG BLDP APD
Hologic $18.3B Take-Private Finalized, CEO Exits as Stock Leaves S&P 500
Markets Daniel Marsh

Hologic $18.3B Take-Private Finalized, CEO Exits as Stock Leaves S&P 500

Hologic has received all required approvals for its $18.3 billion acquisition by Blackstone and TPG, with the deal closing around April 7. CEO Steve MacMillan will retire upon completion.

HOLX BX SIEGY GEHC BDX CASY
Nvidia's Slurm Acquisition Sparks AI Ecosystem Control Concerns
Technology Sarah Chen

Nvidia's Slurm Acquisition Sparks AI Ecosystem Control Concerns

Nvidia's acquisition of SchedMD, the developer behind the Slurm workload manager, has ignited concerns about potential hardware favoritism in AI and supercomputing. The chip giant asserts it will maintain Slurm's open-source, vendor-neutral status.

NVDA AVGO GOOG GOOGL MSFT AMZN META
Enovix Surges 12% Amid Analyst Shifts; Indian Markets Slump on Oil Spike
Markets Daniel Marsh

Enovix Surges 12% Amid Analyst Shifts; Indian Markets Slump on Oil Spike

Enovix shares rallied nearly 12% on Monday despite below-average volume and divergent analyst views. Meanwhile, Indian equity indices tumbled over 800 points as Brent crude surged past $111, stoking inflation fears.

ENVX SBH VGZ FXI MCHI USO
Neurocrine Acquires Soleno in $2.9B Deal for Rare Disease Drug Vykat XR
Markets Daniel Marsh

Neurocrine Acquires Soleno in $2.9B Deal for Rare Disease Drug Vykat XR

Neurocrine Biosciences will purchase Soleno Therapeutics in a $2.9 billion all-cash transaction, securing the commercial rights to Vykat XR. The deal offers $53 per share to Soleno stockholders.

NBIX
Markets Edge Higher on Iran Truce Prospects; Oil Holds Above $110
Markets Daniel Marsh

Markets Edge Higher on Iran Truce Prospects; Oil Holds Above $110

U.S. equities advanced for a fourth straight session Monday, buoyed by hopes for a de-escalation in the Middle East. Oil prices remained elevated above $110 a barrel.

STX TSLA WDC MU USO
CenterPoint Energy Sees Divergent Institutional Moves Ahead of Q1 Report
Earnings James Calloway

CenterPoint Energy Sees Divergent Institutional Moves Ahead of Q1 Report

Institutional investors showed mixed sentiment toward CenterPoint Energy in Q4, with Aberdeen and Stratos cutting positions while Allspring added shares. The utility reports first-quarter results on April 23.

CNP
Oklo Insider Sales Clarified at $11M, Not $21M, Amid Revenue-Less 2025
Earnings James Calloway

Oklo Insider Sales Clarified at $11M, Not $21M, Amid Revenue-Less 2025

Regulatory filings show Oklo co-founders and the CFO sold approximately $10.9 million in shares, correcting earlier reports of $21 million in sales. The company reported no revenue and a significant net loss for 2025.

OKLO META MSFT GS C
Microsoft's AI Ambitions Face Investor Scrutiny Over Costs and Concentration
Technology Sarah Chen

Microsoft's AI Ambitions Face Investor Scrutiny Over Costs and Concentration

Microsoft's stock remains under pressure following its worst quarterly performance since 2008, with investors focused on massive capital expenditures for AI infrastructure and significant commercial reliance on OpenAI.

MSFT AMZN GOOGL META AAPL NVDA XLK
UnitedHealth Shares Rally on Medicare Advantage Rate Decision Ahead of Q1 Report
Earnings James Calloway

UnitedHealth Shares Rally on Medicare Advantage Rate Decision Ahead of Q1 Report

UnitedHealth Group shares advanced following a finalized 2.48% increase to 2027 Medicare Advantage payment rates, which exceeds initial projections. The company is set to report first-quarter results on April 21 amid expectations for an earnings decline.

UNH HUM CVS XLV
Amazon Imposes 3.5% Fuel Surcharge on Sellers Amid Rising Oil Prices
Economy Daniel Marsh

Amazon Imposes 3.5% Fuel Surcharge on Sellers Amid Rising Oil Prices

Amazon is introducing a 3.5% fuel and logistics surcharge on fulfillment fees for third-party sellers in the U.S. and Canada, effective April 17. The move comes as Brent crude oil prices hover around $110 per barrel, increasing delivery costs across the logistics sector.

AMZN FDX UPS USO